Literature DB >> 17186023

Regulation of developmental rate and germ cell proliferation in Caenorhabditis elegans by the p53 gene network.

W B Derry1, R Bierings, M van Iersel, T Satkunendran, V Reinke, J H Rothman.   

Abstract

Caenorhabditis elegans CEP-1 activates germline apoptosis in response to genotoxic stress, similar to its mammalian counterpart, tumor suppressor p53. In mammals, there are three p53 family members (p53, p63, and p73) that activate and repress many distinct and overlapping sets of genes, revealing a complex transcriptional regulatory network. Because CEP-1 is the sole p53 family member in C. elegans, analysis of this network is greatly simplified in this organism. We found that CEP-1 functions during normal development in the absence of stress to repress many (331) genes and activate only a few (28) genes. In response to genotoxic stress, 1394 genes are activated and 942 are repressed, many of which contain p53-binding sites. Comparison of the CEP-1 transcriptional network with transcriptional targets of the human p53 family reveals considerable overlap between CEP-1-regulated genes and homologues regulated by human p63 and p53, suggesting a composite p53/p63 action for CEP-1. We found that phg-1, the C. elegans Gas1 (growth arrest-specific 1) homologue, is activated by CEP-1 and is a negative regulator of cell proliferation in the germline in response to genotoxic stress. Further, we find that CEP-1 and PHG-1 mediate the decreased developmental rate and embryonic viability of mutations in the clk-2/TEL2 gene, which regulates lifespan and checkpoint responses.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17186023     DOI: 10.1038/sj.cdd.4402075

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  34 in total

Review 1.  p63 and p73, the ancestors of p53.

Authors:  V Dötsch; F Bernassola; D Coutandin; E Candi; G Melino
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-05-19       Impact factor: 10.005

Review 2.  Phylogeny and function of the invertebrate p53 superfamily.

Authors:  Rachael Rutkowski; Kay Hofmann; Anton Gartner
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-05-05       Impact factor: 10.005

Review 3.  Cancer models in Caenorhabditis elegans.

Authors:  Natalia V Kirienko; Kumaran Mani; David S Fay
Journal:  Dev Dyn       Date:  2010-05       Impact factor: 3.780

4.  Analysis of the oligomeric state and transactivation potential of TAp73α.

Authors:  L M Luh; S Kehrloesser; G B Deutsch; J Gebel; D Coutandin; B Schäfer; M Agostini; G Melino; V Dötsch
Journal:  Cell Death Differ       Date:  2013-03-29       Impact factor: 15.828

5.  Genome-wide analysis of germ cell proliferation in C.elegans identifies VRK-1 as a key regulator of CEP-1/p53.

Authors:  Katherine Waters; Alison Z Yang; Valerie Reinke
Journal:  Dev Biol       Date:  2010-06-23       Impact factor: 3.582

6.  The EEL-1 ubiquitin ligase promotes DNA damage-induced germ cell apoptosis in C. elegans.

Authors:  A J Ross; M Li; B Yu; M X Gao; W B Derry
Journal:  Cell Death Differ       Date:  2011-01-14       Impact factor: 15.828

Review 7.  p53 ancestry: gazing through an evolutionary lens.

Authors:  Wan-Jin Lu; James F Amatruda; John M Abrams
Journal:  Nat Rev Cancer       Date:  2009-10       Impact factor: 60.716

Review 8.  An overview of stress response and hypometabolic strategies in Caenorhabditis elegans: conserved and contrasting signals with the mammalian system.

Authors:  Benjamin Lant; Kenneth B Storey
Journal:  Int J Biol Sci       Date:  2010-01-07       Impact factor: 6.580

9.  Nucleolar proteins suppress Caenorhabditis elegans innate immunity by inhibiting p53/CEP-1.

Authors:  Laura E Fuhrman; Ajay Kumar Goel; Jason Smith; Kevin V Shianna; Alejandro Aballay
Journal:  PLoS Genet       Date:  2009-09-18       Impact factor: 5.917

10.  Functional dissection of Caenorhabditis elegans CLK-2/TEL2 cell cycle defects during embryogenesis and germline development.

Authors:  Sandra C Moser; Sophie von Elsner; Ingo Büssing; Arno Alpi; Ralf Schnabel; Anton Gartner
Journal:  PLoS Genet       Date:  2009-04-10       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.